For example, in the early stages of esophageal cancer, the expression of ORF1p was detected in Barret’s esophagus [70], which poses a selective pressure that may favor the inactivation of TP53, the most common event in esophageal cancer (~65% of patients). This evidence concerns the gene TP53 and esophageal cancer.